Larotrectinib

BIGBEAR Pharmaceutical announces the approval of Larotrectinib in Laos

Vientiane, Laos - May 30, 2024 - BigBear Pharma, a leading biopharmaceutical company focused on developing and commercializing innovative cancer treatments, today announced that Larotrectinib have been approved by the Ministry of Health of Laos. Approved drugs are: Larotrectinib sold under the brand name LARODX.  Larotrectinib is an inhibitor of tropomyosin kinase…